Clinical Trial Update: Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, tolerability, and acceptability of long-acting HIV integrase inhibitor GSK1265744 in HIV-uninfected men; study completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• GSK1265744 (dolutegravir? wait: GSK1265744 is cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2017-12-15